These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 32936290)
21. RP11-81H3.2 Acts as an Oncogene via microRNA-490-3p Inhibition and Consequential Tankyrase 2 Up-Regulation in Hepatocellular Carcinoma. Chen W; Li K; Zhu K; Yan R; Cai QC; Li WH; Dang CX Dig Dis Sci; 2020 Oct; 65(10):2949-2958. PubMed ID: 31858324 [TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA RP11-909N17.2 presages a poor prognosis of non-small cell lung cancer. Gao W; Liu T; Tuo Z; Ma L; Zhou Z Cancer Biomark; 2022; 34(2):211-219. PubMed ID: 34957995 [TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA matrilineal expression gene 3 inhibits hepatocellular carcinoma progression by targeting microRNA-5195-3p and regulating the expression of forkhead box O1. Li M; Liao H; Wu J; Chen B; Pang R; Huang J; Zhu Y Bioengineered; 2021 Dec; 12(2):12880-12890. PubMed ID: 34895065 [TBL] [Abstract][Full Text] [Related]
24. LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p. Luan X; Wang Y J Gynecol Oncol; 2018 Nov; 29(6):e95. PubMed ID: 30207103 [TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA TUG1 sponges microRNA-381-3p to facilitate cell viability and attenuate apoptosis in cervical cancer by elevating MDM2 expression. Liu J; Wu D; Lin X; Hong Y; Wang X; Zheng C; Wu Z; Hong Y; Lv Y Life Sci; 2021 Feb; 267():118902. PubMed ID: 33340525 [TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA LINC00460 promotes the progression of cervical cancer via regulation of the miR-361-3p/Gli1 axis. Li F; Zhu W; Wang Z Hum Cell; 2021 Jan; 34(1):229-237. PubMed ID: 33063235 [TBL] [Abstract][Full Text] [Related]
27. LncRNA RP11-58O9.2 predicts poor prognosis and promotes progression of non-small cell lung cancer. Miao X; Xi W; Bao Y J Int Med Res; 2023 Oct; 51(10):3000605231206295. PubMed ID: 37871619 [TBL] [Abstract][Full Text] [Related]
28. RP11-81H3.2 promotes gastric cancer progression through miR-339-HNRNPA1 interaction network. Chen FR; Sha SM; Wang SH; Shi HT; Dong L; Liu D; Cheng Y; An M; Wang Y; Zhang J Cancer Med; 2020 Apr; 9(7):2524-2534. PubMed ID: 32052594 [TBL] [Abstract][Full Text] [Related]
29. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo. Shi J; Tan S; Song L; Song L; Wang Y Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117 [TBL] [Abstract][Full Text] [Related]
30. LINC01605 promotes malignant phenotypes of cervical cancer via miR-149-3p/WNT7B axis. Kong X; Xiong Y; Li L Gene; 2024 Aug; 921():148518. PubMed ID: 38734188 [TBL] [Abstract][Full Text] [Related]
31. SATB1 3'-UTR and lncRNA-UCA1 competitively bind to miR-495-3p and together regulate the proliferation and invasion of gastric cancer. Sun L; Liu L; Yang J; Li H; Zhang C J Cell Biochem; 2019 Apr; 120(4):6671-6682. PubMed ID: 30368875 [TBL] [Abstract][Full Text] [Related]
32. LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression. Bai X; Wang W; Zhao P; Wen J; Guo X; Shen T; Shen J; Yang X Carcinogenesis; 2020 Mar; 41(1):111-121. PubMed ID: 31605132 [TBL] [Abstract][Full Text] [Related]
33. LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway. Mu M; Niu W; Zhang X; Hu S; Niu C Oncogene; 2020 Nov; 39(45):6879-6892. PubMed ID: 32978519 [TBL] [Abstract][Full Text] [Related]
34. Down-regulation of long non-coding RNA RP11-708H21.4 is associated with poor prognosis for colorectal cancer and promotes tumorigenesis through regulating AKT/mTOR pathway. Sun L; Jiang C; Xu C; Xue H; Zhou H; Gu L; Liu Y; Xu Q Oncotarget; 2017 Apr; 8(17):27929-27942. PubMed ID: 28427191 [TBL] [Abstract][Full Text] [Related]
35. Circ_0000388 Exerts Oncogenic Function in Cervical Cancer Cells by Regulating miR-337-3p/ Meng QH; Li Y; Kong C; Gao XM; Jiang XJ Cancer Biother Radiopharm; 2021 Feb; 36(1):58-69. PubMed ID: 32119786 [No Abstract] [Full Text] [Related]
36. LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway. Zhang B; Yu L; Han N; Hu Z; Wang S; Ding L; Jiang J Biomed Pharmacother; 2018 Nov; 107():270-282. PubMed ID: 30098545 [TBL] [Abstract][Full Text] [Related]
37. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway. Xiong L; Tang Y; Tang J; Liu Z; Wang X Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357 [No Abstract] [Full Text] [Related]
38. LncRNA RP11-436H11.5, functioning as a competitive endogenous RNA, upregulates BCL-W expression by sponging miR-335-5p and promotes proliferation and invasion in renal cell carcinoma. Wang K; Jin W; Song Y; Fei X Mol Cancer; 2017 Oct; 16(1):166. PubMed ID: 29070041 [TBL] [Abstract][Full Text] [Related]
39. Long Non-Coding RNA AC008972.1 as a Novel Therapeutic Target for Prostate Cancer. Zeng Q; Liu J; Wu Q; Song R; Miao W; Ma Y; Yang H Cancer Biother Radiopharm; 2024 May; 39(4):291-305. PubMed ID: 36094409 [No Abstract] [Full Text] [Related]
40. LncRNA RP11-116G8.5 promotes the progression of lung squamous cell carcinoma through sponging miR-3150b-3p/miR-6870-5p to upregulate PHF12/FOXP4. Li H; Zhao Q; Tang Z Pathol Res Pract; 2021 Oct; 226():153566. PubMed ID: 34500373 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]